TrialOncotarget2015

An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma.

Qian Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.